<html>
<head><!-- Global site tag (gtag.js) - Google Analytics -->
<script async src="https://www.googletagmanager.com/gtag/js?id=UA-158181022-1"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'UA-158181022-1');
</script>

<title>Prenatal lower urinary tract obstruction </title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<script language="JavaScript">
<!--
<!--
function MM_reloadPage(init) {  //reloads the window if Nav4 resized
  if (init==true) with (navigator) {if ((appName=="Netscape")&&(parseInt(appVersion)==4)) {
    document.MM_pgW=innerWidth; document.MM_pgH=innerHeight; onresize=MM_reloadPage; }}
  else if (innerWidth!=document.MM_pgW || innerHeight!=document.MM_pgH) location.reload();
}
MM_reloadPage(true);
// -->

function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_findObj(n, d) { //v4.0
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && document.getElementById) x=document.getElementById(n); return x;
}

function MM_nbGroup(event, grpName) { //v3.0
  var i,img,nbArr,args=MM_nbGroup.arguments;
  if (event == "init" && args.length > 2) {
    if ((img = MM_findObj(args[2])) != null && !img.MM_init) {
      img.MM_init = true; img.MM_up = args[3]; img.MM_dn = img.src;
      if ((nbArr = document[grpName]) == null) nbArr = document[grpName] = new Array();
      nbArr[nbArr.length] = img;
      for (i=4; i < args.length-1; i+=2) if ((img = MM_findObj(args[i])) != null) {
        if (!img.MM_up) img.MM_up = img.src;
        img.src = img.MM_dn = args[i+1];
        nbArr[nbArr.length] = img;
    } }
  } else if (event == "over") {
    document.MM_nbOver = nbArr = new Array();
    for (i=1; i < args.length-1; i+=3) if ((img = MM_findObj(args[i])) != null) {
      if (!img.MM_up) img.MM_up = img.src;
      img.src = (img.MM_dn && args[i+2]) ? args[i+2] : args[i+1];
      nbArr[nbArr.length] = img;
    }
  } else if (event == "out" ) {
    for (i=0; i < document.MM_nbOver.length; i++) {
      img = document.MM_nbOver[i]; img.src = (img.MM_dn) ? img.MM_dn : img.MM_up; }
  } else if (event == "down") {
    if ((nbArr = document[grpName]) != null)
      for (i=0; i < nbArr.length; i++) { img=nbArr[i]; img.src = img.MM_up; img.MM_dn = 0; }
    document[grpName] = nbArr = new Array();
    for (i=2; i < args.length-1; i+=2) if ((img = MM_findObj(args[i])) != null) {
      if (!img.MM_up) img.MM_up = img.src;
      img.src = img.MM_dn = args[i+1];
      nbArr[nbArr.length] = img;
  } }
}
//-->
</script>
<style type="text/css">
<!--
#apDiv1 {
	position:absolute;
	left:49px;
	top:1228px;
	width:1252px;
	height:776px;
	z-index:9;
}
#apDiv2 {
	position:absolute;
	left:300px;
	top:417px;
	width:137px;
	height:42px;
	z-index:10;
}
-->
</style>
<script type="text/javascript">

  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-17648363-4']);
  _gaq.push(['_trackPageview']);

  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();

</script>
</head>

<body bgcolor="#FFFFFF" text="#000000" onLoad="MM_preloadImages('images/navigation/ndsbuttons/about.jpg','images/navigation/ndsbuttons/chiefed.jpg','images/navigation/ndsbuttons/seced.jpg','images/navigation/ndsbuttons/contributors.jpg','images/navigation/ndsbuttons/contents.jpg','images/navigation/ndsbuttons/sponsores.jpg','images/navigation/ndsbuttons/contact.jpg','images/navigation/ndsbuttons/button.jpg')">
<div id="banner" style="position:absolute; left:18px; top:12px; width:1558px; height:109px; z-index:1; background-color: #009999; layer-background-color: #009999; border: 1px none #000000"><img src="images/graphics/banner%20copy.jpg" width="1558" height="109"></div>
<div id="maintxt" style="position:absolute; left:284px; top:151px; width:1100px; height:236px; z-index:4; background-color: #33FFFF; layer-background-color: #33FFFF; border: 1px none #000000"> 
    <h2><strong>Prenatal  lower urinary tract obstruction</strong><strong> </strong><br>
      &nbsp;<br>
      Dr. Masami  Yamamoto1, Dr. Pedro-Jos&eacute; L&oacute;pez2<br>
      Maternal Fetal  Medicine &amp; Paediatric Urology Department<br>
      Hospital Padre  Hurtado1, Hospital Exequiel Gonzalez Cortes2 &amp; <br>
      Cl&iacute;nica Alemana  Santiago<br>
    Santiago-Chile</h2>
  <p align="center" id="translator-p"><a href="https://pediatricurologybook.com/es/libro/capitulo/4-20_obstruccion_prenatal_del_tracto_urinario_inferior.html">&rarr; Enlace a la versi&oacute;n en espa&ntilde;ol</a></p>
  <blockquote>&nbsp;</blockquote>
</div>
<div id="editors" style="position:absolute; left:302px; top:477px; width:998px; height:710px; z-index:5">
  <p><strong>Introduction</strong><br>
    Lower  urinary tract obstruction (LUTO) is due to posterior urethral valves (PUV) in  up to half of the cases, urethral atresia being the second most frequent  condition. It occurs more frequently in male fetuses; when it affects females  the diagnosis should always be considered doubtful and probably attributed to  megacolon, vaginal abnormalities or other differential diagnoses. The disease  is relatively infrequent, with a reported incidence of 2 every 10.000 births in  England. The main interest of this disease is that antenatal therapy has been  developed to shunt the fetal urine to the amniotic cavity, and preserve renal  function. Nevertheless, the selection criteria are rigorous and not all males  with LUTO are suitable for antenatal intervention.</p>
  <p><strong>Diagnosis</strong><br>
    Diagnosis  can be made from the first trimester by ultrasonography, usually performed at  11 to 14 weeks. The bladder is normally visualized in a sagittal view,  measuring not more than 1 cm in most cases. When is associated with other  abnormalities such as increased nuchal translucency or malformations, the  suspicion of an associated aneuploidy is strengthened. </p>
  <p>In  the second trimester, the bladder is normally bigger in size, with important  variation in growing phase and micturition.&nbsp;  Typical characteristics are the size of the bladder and bilateral pyelectasia  or even hydronephrosis as LUTO produces retrograde urinary tract dilation. The  characteristic sonographic image of the &ldquo;keyhole sign&rdquo; is described when the  upper urethra and the bladder are dilated. However, this is not a constant  finding. </p>
  <p>Antenatally  LUTO is diagnosed by the detection of a distended bladder that does not empty,  unilateral or bilateral upper tract dilatation with or without oligohydramnios.  In a male fetus with these findings in isolation it must be assumed to be PUV  unless proved otherwise. </p>
  <p>Amnio  infusion has been used to increase the ultrasound diagnosis. Frequently,  oligohydramnios present because of LUTO makes the diagnosis of other  abnormalities difficult.  <br>
  <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
<!-- pedeatric -->
<ins class="adsbygoogle"
     style="display:inline-block;width:728px;height:90px"
     data-ad-client="ca-pub-3271938097114754"
     data-ad-slot="6645742649"></ins>
<script>
(adsbygoogle = window.adsbygoogle || []).push({});
</script></p>
  <p><strong>Karyotype</strong><br>
This  is routinely recommended in all institutions, as fetal gender can be confirmed  and normal karyotype could further select the cases that could benefit from  antenatal treatment. This can be performed by amniocentesis.</p>
  <p><strong>Natural history and prognosis. </strong><br>
    Several  studies consistently demonstrate that mortality is high, around 60%. This  elevated mortality could rise up to 90% whenever persistent oligohydramnios was  associated, with renal morbidity and pulmonary hypoplasia. These cases  developed end stage renal dysfunction in 30% of the cases. Other adverse  prognostic factors are early gestational age at presentation. </p>
  <p>In  LUTO, the postnatal renal impairment is important, as antenatal therapy is not  indicated in cases in which the function is definitely impaired. &nbsp;This is not an easy subject as fetal markers  of function are in continuous evolution. &nbsp;Urinary sodium &lt;90mmol/L&nbsp; is normal at 20 to 30 weeks of gestational  age. Whenever this is found &gt;1Also  an elevation of urinary B2 Microglobulin &gt;13mg/L has been shown to correlate  well with renal impairment, and &gt;6 to be an adverse prognostic factor.&nbsp; Fetuses in which urinary biochemical analysis  shows impaired renal function are not candidates for antenatal therapy1,2. </p>
  <p>Fetal blood creatinine is not a good predictor  as it is normally increased during pregnancy. Fetal blood sodium concentration  is regulated at the placenta is similar to that of the mother. <br>
  </p>
  <p>&nbsp;</p>
              </div>
<div id="Layer1" style="position:absolute; left:624px; top:436px; width:400; height:40; z-index:6"></div>
<div id="Layer2" style="position:absolute; left:19px; top:151px; width:250; height:250; z-index:7"><img src="images/graphics/logo004.jpg" width="250" height="250"></div>
<div id="Layer3" style="position:absolute; left:41px; top:459px; width:203px; height:713px; z-index:8"> 
  <table border="0" cellpadding="0" cellspacing="0">
    <tr>
      <td><a href="about.htm" onClick="MM_nbGroup('down','group1','about','images/navigation/ndsbuttons/about.jpg',1)" onMouseOver="MM_nbGroup('over','about','images/navigation/ndsbuttons/about.jpg','images/navigation/ndsbuttons/about.jpg',1)" onMouseOut="MM_nbGroup('out')"><img name="about" src="images/navigation/ndsbuttons/about.jpg" border="0" onLoad="" width="200" height="80"></a></td>
    </tr>
    <tr>
      <td><a href="chiefeditors.htm" onClick="MM_nbGroup('down','group1','chiefed','images/navigation/ndsbuttons/chiefed.jpg',1)" onMouseOver="MM_nbGroup('over','chiefed','images/navigation/ndsbuttons/chiefed.jpg','images/navigation/ndsbuttons/chiefed.jpg',1)" onMouseOut="MM_nbGroup('out')"><img name="chiefed" src="images/navigation/ndsbuttons/chiefed.jpg" border="0" onLoad="" width="200" height="80"></a></td>
    </tr>
    <tr>
      <td><a href="sectioneditors.htm" onClick="MM_nbGroup('down','group1','sected','images/navigation/ndsbuttons/seced.jpg',1)" onMouseOver="MM_nbGroup('over','sected','images/navigation/ndsbuttons/seced.jpg','images/navigation/ndsbuttons/seced.jpg',1)" onMouseOut="MM_nbGroup('out')"><img name="sected" src="images/navigation/ndsbuttons/seced.jpg" border="0" onLoad="" width="200" height="80"></a></td>
    </tr>
    <tr>
      <td><a href="contributors.htm" onClick="MM_nbGroup('down','group1','contribu','images/navigation/ndsbuttons/contributors.jpg',1)" onMouseOver="MM_nbGroup('over','contribu','images/navigation/ndsbuttons/contributors.jpg','images/navigation/ndsbuttons/contributors.jpg',1)" onMouseOut="MM_nbGroup('out')"><img name="contribu" src="images/navigation/ndsbuttons/contributors.jpg" border="0" onLoad="" width="200" height="80"></a></td>
    </tr>
    <tr>
      <td><a href="contents.htm" onClick="MM_nbGroup('down','group1','contents','images/navigation/ndsbuttons/contents.jpg',1)" onMouseOver="MM_nbGroup('over','contents','images/navigation/ndsbuttons/contents.jpg','images/navigation/ndsbuttons/contents.jpg',1)" onMouseOut="MM_nbGroup('out')"><img name="contents" src="images/navigation/ndsbuttons/contents.jpg" border="0" onLoad="" width="200" height="80"></a></td>
    </tr>
    <tr>
      <td><a href="links.htm" onClick="MM_nbGroup('down','group1','sponsors','images/navigation/ndsbuttons/sponsores.jpg',1)" onMouseOver="MM_nbGroup('over','sponsors','images/navigation/ndsbuttons/sponsores.jpg','images/navigation/ndsbuttons/sponsores.jpg',1)" onMouseOut="MM_nbGroup('out')"><img name="sponsors" src="images/navigation/ndsbuttons/sponsores.jpg" border="0" onLoad="" width="200" height="80"></a></td>
    </tr>
    <tr>
      <td><a href="contact.htm" onClick="MM_nbGroup('down','group1','contact','images/navigation/ndsbuttons/contact.jpg',1)" onMouseOver="MM_nbGroup('over','contact','images/navigation/ndsbuttons/contact.jpg','images/navigation/ndsbuttons/contact.jpg',1)" onMouseOut="MM_nbGroup('out')"><img name="contact" src="images/navigation/ndsbuttons/contact.jpg" border="0" onLoad="" width="200" height="80"></a></td>
    </tr>
    <tr>
      <td><a href="index.htm" onClick="MM_nbGroup('down','group1','home','images/navigation/ndsbuttons/button.jpg',1)" onMouseOver="MM_nbGroup('over','home','images/navigation/ndsbuttons/button.jpg','images/navigation/ndsbuttons/button.jpg',1)" onMouseOut="MM_nbGroup('out')"><img name="home" src="images/navigation/ndsbuttons/button.jpg" border="0" onLoad="" width="200" height="80"></a></td>
    </tr>
  </table>
</div>
<div id="apDiv1">
  <p><strong>Antenatal therapy</strong><br>
    Serial  vesicocentesis, vesicoamniotic shunts and in-utero percutaneous cystoscopy have  been proposed as alternative therapies for LUTO in male fetuses, normal  kayotype and preserved renal function. Some centers support that  oligohydramnios is not a selection criteria, but rather a contraindication, as  these cases could have already an impaired renal function. Antenatal therapy  should be offered when neonatal viability is low, and therefore delivery is not  an option.</p>
  <p>Serial  vesicocentesis is performed at no less than two week intervals with fine  needles &gt;21G, guided by ultrasound in hands of experienced fetal medicine  specialists. The aim is to decompress the bladder and preserve urinary function  until delivery. The problem of this approach is that several procedures could  increase the risk of miscarriage.</p>
  <p>Vesicoamniotic  shunts are double pig-tailed catheters that can be inserted percutanously,  under ultrasound guidance, in which one end is inserted into the bladder and  the other left in the amniotic cavity, through the fetal anterior abdominal  wall. The procedure aims to leave a continuous drainage of the fetal urine to  the amniotic cavity that can preserve renal function. A review of 169 cases3  showed that the overall survival was 47%, in which 40% of survivors had  end-stage renal disease. </p>
  <p>The  procedure had important complications explaining the low survival such as  blockage in 25%, displacement in 20%, preterm labour, miscarriage,  chorioamnionitis. Displacement can leave a vesico-amniotic fistula than could  continue to be therapeutic, but fetal vesico-abdominal fistula can be produced,  leading to ascitis ad sequelae4. </p>
  <p>Fetal  cystocopy is performed percutaneously, under local anesthesia as fetoscopy. The  endocope is inserted into the distended bladder, and mechanical or laser  ablation of PUV is intended5. The problem is that  frequently, the ablation produces either a perineal fistula -that produces  bladder drainage but important perineal lesions-&nbsp; or a urethra stricture, especially if it is  done with laser; therefore until the technology improves is still not an  option.<br>
  <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
<!-- pedeatric -->
<ins class="adsbygoogle"
     style="display:inline-block;width:728px;height:90px"
     data-ad-client="ca-pub-3271938097114754"
     data-ad-slot="6645742649"></ins>
<script>
(adsbygoogle = window.adsbygoogle || []).push({});
</script></p>
  <p><strong>Results:</strong><br>
Until  2003, after 25 years of history and treated cases, with more than 300 treated  fetuses, a review6  demonstrated that there were no randomized studies. Perinatal survival appeared  to improve as compared to the non-drainage group (OR 2.5, 95% CI 1-5.9,  p&lt;0.03). This was even stronger in cases defined as poor prognosis (OR 8.9,  95% CI 1.2-52.9 p&lt;0.03. )</p>
  <p><strong>Conclusion:</strong><br>
    Lower  urinary tract obstruction is variable in severity and sometimes associated with  high mortality. Adverse prognostic factors should be better identified to  select those cases that will not invariably die and that may benefit from  bladder decompression. Randomized trials are needed to support the indication  for intervention. &nbsp;</p>
  <p><strong>&nbsp;</strong></p>
  <p><strong>&nbsp;</strong></p>
  <p><strong>&nbsp;</strong></p>
  <p><strong>References</strong></p>
  <p>1. Johnson MP, Corsi P, Bradfield W et al:  Sequential urinalysis<br>
    improves evaluation of fetal renal function in  obstructive uropathy.<br>
    Am J Obstet Gynecol 173: 59, 1995<br>
    2. Johnson MP, Bukowski TP, Reitleman C, et al: In  utero surgical<br>
    treatment of fetal obstructive uropathy:A new  comprehensive approach<br>
    to identify appropriate candidates for  vesicoamniotic shunt therapy.<br>
    Am J Obstet Gynecol 170: 1770,  1994.<br>
    3. Manning FA, Harrison MR, Rodeck C: Catheter  shunts for fetal<br>
    hydronephrosis and hydrocephalus: Report of the  International Fetal<br>
    Surgery Regsitry.N Engl J Med 315: 336, 1986.<br>
    4. Crombleholme TM, Harrison MR, Golbus MS, et al:  Fetal intervention in<br>
    obstructive uropathy: prognositic indicators and  efficacy of<br>
    intervention. Am J Obstet Gynecol 62: 1239, 1990.<br>
    5. Quintero RA, Hume R, Smith C, et al: Percutaenous  fetal cystoscopy and<br>
    endoscopic fulguration of posterior urethral valves.  Am J Obstet<br>
    Gynecol 172; 206,1995.<br>
    6. Freedman AL, Johnson mP, Smith CA, et al: Long term  outcome in<br>
    chilndren aftere antenatal intervention for  obstructive uropathies.<br>
    Lancet 345: 374, 1999.<script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
<!-- pedeatric -->
<ins class="adsbygoogle"
     style="display:inline-block;width:728px;height:90px"
     data-ad-client="ca-pub-3271938097114754"
     data-ad-slot="6645742649"></ins>
<script>
(adsbygoogle = window.adsbygoogle || []).push({});
</script></p>
  <p>&nbsp;</p>
</div>
<div id="apDiv2"><style type="text/css">
@import url(//www.google.com/cse/api/branding.css);
</style>
<div class="cse-branding-bottom" style="background-color:#FFFFFF;color:#000000">
  <div class="cse-branding-form">
    <form action="http://www.google.com" id="cse-search-box">
      <div>
        <input type="hidden" name="cx" value="partner-pub-3271938097114754:5029408643" />
        <input type="hidden" name="ie" value="UTF-8" />
        <input type="text" name="q" size="30" />
        <input type="submit" name="sa" value="Search" />
      </div>
    </form>
  </div>
  <div class="cse-branding-logo">
    <img src="http://www.google.com/images/poweredby_transparent/poweredby_FFFFFF.gif" alt="Google" />
  </div>
  <div class="cse-branding-text">
    Custom Search
  </div>
</div>
</div>
</body>
</html>
